Protein detail

AT2B1

Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)

Protein symbol
AT2B1
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
10
Protein classification
Disease related genesEnzymesFDA approved drug targetsMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)
Protein Class
Disease related genesEnzymesFDA approved drug targetsMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters
Protein Function
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
Transmembrane
106..126; Helical; 155..175; Helical; 367..386; Helical; 419..439; Helical; 856..876; Helical; 883..903; Helical; 928..948; Helical; 972..991; Helical; 1006..1027; Helical; 1040..1060; Helical
Transmembrane Count
10
Entrez Gene Symbol
Gene Synonym
PMCA1
Gene Description
ATPase plasma membrane Ca2+ transporting 1
Chromosome
12
Position
89588049-89709366
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Tissue SpecificesophagusCell SpecificBasal keratinocytesSingle-Nuclei Brain Specificamygdala excitatory
Function & Pathway
Protein Function
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation
Relations & Evidence

Enzyme-Mediated Modification

3 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
ATP2B1PRKACAP17612S1,178phosphorylationHPRDKEAKEA:2548572HPRD:2548572HPRD:19651622HPRD:20068231KEA:17081983HPRD:18669648
ATP2B1INSP01308S474phosphorylationREACH_ProtMapperProtMapperProtMapper:29104511
ATP2B1PRKCAP17252T1,116phosphorylationKEAKEA:1827443

Ligand-Receptor Signaling

18 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorOmniPathNoYesNoNoNo
intracellularintracellularLOCATENoNoNoNoNo
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularUniProt_locationNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo
transmembranetransmembraneUniProt_locationNoNoNoNoNo
transmembranetransmembraneUniProt_topologyNoNoNoNoNo
transmembranetransmembraneUniProt_keywordNoNoNoNoNo
transmembranetransmembraneTopDBNoNoNoNoNo
Page 1 of 2Next

Regulatory Interaction Network

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
KAPCAP17612AT2B1P20020YesYesYesWangphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperHPRDCui2007PhosphoSite_KEAKEACA1HPRD_KEASIGNOR_ProtMapperHPRD-phosKEA:2548572HPRD:2548572ProtMapper:19651622KEA:17081983ProtMapper:20068231HPRD-phos:20068231HPRD-phos:18669648HPRD-phos:2548572CA1:9824678ProtMapper:2548572ProtMapper:18669648SIGNOR:2548572HPRD-phos:19651622

Protein Complex Composition

0 records.

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyMass spectrometry3377869184074865827894104
Sequence, Structure & Domains

Sequences

Length
1,220
Mass
134,685
Sequence
MGDMANNSVAYSGVKNSLKEANHDGDFGITLAELRALMELRSTDALRKIQESYGDVYGICTKLKTSPNEGLSGNPADLERREAVFGKNFIPPKKPKTFLQLVWEALQDVTLIILEIAAIVSLGLSFYQPPEGDNALCGEVSVGEEEGEGETGWIEGAAILLSVVCVVLVTAFNDWSKEKQFRGLQSRIEQEQKFTVIRGGQVIQIPVADITVGDIAQVKYGDLLPADGILIQGNDLKIDESSLTGESDHVKKSLDKDPLLLSGTHVMEGSGRMVVTAVGVNSQTGIIFTLLGAGGEEEEKKDEKKKEKKNKKQDGAIENRNKAKAQDGAAMEMQPLKSEEGGDGDEKDKKKANLPKKEKSVLQGKLTKLAVQIGKAGLLMSAITVIILVLYFVIDTFWVQKRPWLAECTPIYIQYFVKFFIIGVTVLVVAVPEGLPLAVTISLAYSVKKMMKDNNLVRHLDACETMGNATAICSDKTGTLTMNRMTVVQAYINEKHYKKVPEPEAIPPNILSYLVTGISVNCAYTSKILPPEKEGGLPRHVGNKTECALLGLLLDLKRDYQDVRNEIPEEALYKVYTFNSVRKSMSTVLKNSDGSYRIFSKGASEIILKKCFKILSANGEAKVFRPRDRDDIVKTVIEPMASEGLRTICLAFRDFPAGEPEPEWDNENDIVTGLTCIAVVGIEDPVRPEVPDAIKKCQRAGITVRMVTGDNINTARAIATKCGILHPGEDFLCLEGKDFNRRIRNEKGEIEQERIDKIWPKLRVLARSSPTDKHTLVKGIIDSTVSDQRQVVAVTGDGTNDGPALKKADVGFAMGIAGTDVAKEASDIILTDDNFTSIVKAVMWGRNVYDSISKFLQFQLTVNVVAVIVAFTGACITQDSPLKAVQMLWVNLIMDTLASLALATEPPTESLLLRKPYGRNKPLISRTMMKNILGHAFYQLVVVFTLLFAGEKFFDIDSGRNAPLHAPPSEHYTIVFNTFVLMQLFNEINARKIHGERNVFEGIFNNAIFCTIVLGTFVVQIIIVQFGGKPFSCSELSIEQWLWSIFLGMGTLLWGQLISTIPTSRLKFLKEAGHGTQKEEIPEEELAEDVEEIDHAERELRRGQILWFRGLNRIQTQIRVVNAFRSSLYEGLEKPESRSSIHNFMTHPEFRIEDSEPHIPLIDDTDAEDDAPTKRNSSPPPSPNKNNNAVDSGIHLTIEMNKSATSSSPGSPLHSLETSL
Alternative Products
Event=Alternative splicing; Named isoforms=6; Name=B; Synonyms=CI, hPMCA1b; IsoId=P20020-3; Sequence=Displayed; Name=D; Synonyms=CIV, hPMCA1d; IsoId=P20020-1; Sequence=VSP_059773; Name=A; Synonyms=CII, hPMCA1a; IsoId=P20020-2; Sequence=VSP_059774, VSP_059775; Name=C; Synonyms=CIII, hPMCA1c; IsoId=P20020-4; Sequence=VSP_059772; Name=E; Synonyms=CV; IsoId=P20020-5; Sequence=VSP_059774, VSP_059776; Name=K; IsoId=P20020-6; Sequence=VSP_059771
Alternative Sequence
1021..1056; Missing (in isoform K); 1117; Q -> QMDVVNAFQSGSSIQGALRRQPSIASQHHD (in isoform C); 1117; Q -> QMDVVNAFQSGSSIQGALRRQPSIASQHHDVTNISTPTH (in isoform D); 1118..1119; IR -> MD (in isoform A and isoform E); 1125..1220; RSSLYEGLEKPESRSSIHNFMTHPEFRIEDSEPHIPLIDDTDAEDDAPTKRNSSPPPSPNKNNNAVDSGIHLTIEMNKSATSSSPGSPLHSLETSL -> QSGSSIQGALRRQPSIASQHHDVTNISTPTHVVFSSSTASTTVGYSSGECIS (in isoform A); 1125..1220; RSSLYEGLEKPESRSSIHNFMTHPEFRIEDSEPHIPLIDDTDAEDDAPTKRNSSPPPSPNKNNNAVDSGIHLTIEMNKSATSSSPGSPLHSLETSL -> QSGSSIQGALRRQPSIASQHHDVTNISTPTHVVFSSSTASTTVGFEW (in isoform E)

3D Structural Models

3D Structure
Electron microscopy (1)

Domain & Motif Annotations

Compositional Bias
312..325; Basic and acidic residues; 337..356; Basic and acidic residues; 1200..1220; Polar residues
Domain (CC)
Isoforms A, C, D and E contain an additional calmodulin-binding subdomain B which is different in the different splice variants and shows pH dependent calmodulin binding properties.
Region
297..356; Disordered; 1100..1117; Calmodulin-binding subdomain A; 1118..1220; Required for basolateral membrane targeting; 1160..1220; Disordered
Protein Families
  • Cation transport ATPase (P-type) (TC 3.A.3) family
  • Type IIB subfamily
Sequence Similarities
Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type IIB subfamily.
Clinical Relevance
Disease Involvement
Disease variantFDA approved drug targetsIntellectual disability
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000067842ENSG00000149136ENSG00000156642ENSG00000172270ENSG00000198668
Interaction Count
5
Interaction Dataset
biogrid_opencell